x
ServiziMenu principaleHome
Home > Sponsors & Exhibition > Sponsored satellite symposia
Print

Sponsored satellite symposia

Thursday, 14 November


18:00 -19:30 Sponsored satellite symposium 3 Daiichi Sankyo Europe

AstraZeneca

HER2 targeted therapies in metastatic Breast Cancer - Current Status and Emerging Options
Chair: Chris Twelves, UK

18:00 Introduction + objectives of the meeting (Chris Twelves, UK)
18:10 Current challenges in HER2 targeted therapies – where do we need further improvement?
          - The clinician’s perspective (Sofia Braga, PT)
          - The pathologist’s perspective (Giuseppe Viale, IT)
18:40 How can new technologies fill the medical gap in HER driven metastatic Breast Cancer? (Peter Fasching, DE)
18:55 Clinical study programs to optimize personalized medicine in Her2 metastatic breast cancer
          (Jean-Yves Pierga, FR)
19:10 Panel discussion (All and moderated by Chris Twelves, UK)
19:25 Key take away and closing (Chris Twelves, UK)

Symposium faculty
Chris Twelves, Clinical Cancer Pharmacology and Oncology, Leeds, United Kingdom
Giuseppe Viale, San Raffaele Scientific Institute, Milan, Italy
Peter Fasching, University Erlangen, Erlangen, Germany
Jean-Yves Pierga, Institut Curie, Paris, France
Sofia Braga, Minho University, Braga, Portugal